PL2202307T3 - Sposób wytwarzania przeciwciała - Google Patents

Sposób wytwarzania przeciwciała

Info

Publication number
PL2202307T3
PL2202307T3 PL08838661T PL08838661T PL2202307T3 PL 2202307 T3 PL2202307 T3 PL 2202307T3 PL 08838661 T PL08838661 T PL 08838661T PL 08838661 T PL08838661 T PL 08838661T PL 2202307 T3 PL2202307 T3 PL 2202307T3
Authority
PL
Poland
Prior art keywords
antibody
production
Prior art date
Application number
PL08838661T
Other languages
English (en)
Other versions
PL2202307T5 (pl
Inventor
Yoshiki Yamada
Tatsuya Kiyasu
Kazuyuki Tabata
Akihiro Kuzumaki
Mai Yamashiro
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2202307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of PL2202307T3 publication Critical patent/PL2202307T3/pl
Publication of PL2202307T5 publication Critical patent/PL2202307T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PL08838661T 2007-10-15 2008-10-14 Sposób wytwarzania przeciwciała PL2202307T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007267384 2007-10-15
JP2008103308 2008-04-11
PCT/JP2008/068588 WO2009051108A1 (ja) 2007-10-15 2008-10-14 抗体の製造方法
EP08838661.0A EP2202307B2 (en) 2007-10-15 2008-10-14 Method for production of antibody

Publications (2)

Publication Number Publication Date
PL2202307T3 true PL2202307T3 (pl) 2015-02-27
PL2202307T5 PL2202307T5 (pl) 2021-10-04

Family

ID=40567372

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08838661T PL2202307T5 (pl) 2007-10-15 2008-10-14 Sposób wytwarzania przeciwciała

Country Status (17)

Country Link
US (3) US9683027B2 (pl)
EP (1) EP2202307B2 (pl)
JP (4) JP4976502B2 (pl)
KR (1) KR101558009B1 (pl)
CN (3) CN101802192A (pl)
AU (1) AU2008312937B2 (pl)
BR (1) BRPI0818674B1 (pl)
CA (1) CA2701338C (pl)
DK (1) DK2202307T4 (pl)
ES (1) ES2499391T5 (pl)
IL (2) IL205051A (pl)
MX (1) MX2010004007A (pl)
PL (1) PL2202307T5 (pl)
SG (1) SG185302A1 (pl)
SI (1) SI2202307T2 (pl)
TW (1) TWI463010B (pl)
WO (1) WO2009051108A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG185302A1 (en) 2007-10-15 2012-11-29 Chugai Pharmaceutical Co Ltd Method for production of antibody
SI2493922T1 (sl) 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
CN103282509A (zh) * 2010-12-28 2013-09-04 中外制药株式会社 动物细胞的培养方法
JP2016513478A (ja) * 2013-03-15 2016-05-16 ジェネンテック， インコーポレイテッド 細胞培養培地及び抗体を産生する方法
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
WO2018002036A1 (en) 2016-06-28 2018-01-04 Zaklady Farmaceutyczne Polpharma Sa Recombinant production of monoclonal antibodies
EP3541413A2 (en) 2016-11-21 2019-09-25 Polpharma Biologics S.A. Aqueous pharmaceutical formulations
WO2025134341A1 (ja) * 2023-12-22 2025-06-26 中外製薬株式会社 抗体の製造方法
WO2025141786A1 (ja) * 2023-12-27 2025-07-03 中外製薬株式会社 抗体の製造方法
WO2025232879A1 (en) 2024-05-10 2025-11-13 Cytocares (Shanghai) Inc. Anti-lilrb2 monospecific and bispecific antibody constructs and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPS6459878A (en) 1987-08-31 1989-03-07 Matsushita Electric Industrial Co Ltd Semiconductor laser protective circuit
WO1996033735A1 (en) 1995-04-27 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
WO1993012227A1 (en) 1991-12-17 1993-06-24 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
EP0548267A4 (en) † 1990-09-04 1994-11-23 Salk Inst Biotech Ind Production of insulin-like growth factor-1 in methylotrophic yeast cells
US5795965A (en) 1991-04-25 1998-08-18 Chugai Seiyaku Kabushiki Kaisha Reshaped human to human interleukin-6 receptor
EP0605522B1 (en) 1991-09-23 1999-06-23 Medical Research Council Methods for the production of humanized antibodies
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
CA2131151A1 (en) 1992-03-24 1994-09-30 Kevin S. Johnson Methods for producing members of specific binding pairs
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
JPH08509612A (ja) 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド 異種抗体を産生することができるトランスジェニック非ヒト動物
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
WO1995015388A1 (en) 1993-12-03 1995-06-08 Medical Research Council Recombinant binding proteins and peptides
US5531053A (en) 1994-06-14 1996-07-02 Hamm; Hans Spring fastener for holding insulation against an inner surface of cavity walling
DE69535243T2 (de) 1994-07-13 2007-05-10 Chugai Seiyaku K.K. Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
US5561053A (en) 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1998047343A2 (en) * 1997-04-04 1998-10-29 Biosite Diagnostics, Inc. Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
ATE299938T1 (de) 1997-05-02 2005-08-15 Genentech Inc Ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
AU2002307037B2 (en) † 2001-04-02 2008-08-07 Biogen Idec Inc. Recombinant antibodies coexpressed with GnTIII
US6605176B2 (en) 2001-07-13 2003-08-12 Taiwan Semiconductor Manufacturing Co., Ltd. Aperture for linear control of vacuum chamber pressure
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
MXPA04004634A (es) * 2001-11-16 2004-08-12 Idec Pharma Corp Expresion policistronica de anticuerpos.
DE602004030451D1 (de) 2003-07-15 2011-01-20 Chugai Pharmaceutical Co Ltd Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion
CA2559280A1 (en) * 2004-03-15 2005-09-29 Biogen Idec Ma Inc. Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
SI1674111T1 (sl) * 2004-07-09 2011-02-28 Chugai Pharmaceutical Co Ltd Protitelo proti glipikanu 3
GB0425534D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
MX2008000985A (es) * 2005-07-21 2008-04-07 Abbott Lab Expresion de gen multiple que incluye construcciones y metodos sorf (cuadro de lectura abierta simple) con poliproteinas, pro-proteinas y proteolisis.
SG185302A1 (en) * 2007-10-15 2012-11-29 Chugai Pharmaceutical Co Ltd Method for production of antibody

Also Published As

Publication number Publication date
IL240122A0 (en) 2015-09-24
JPWO2009051108A1 (ja) 2011-03-03
BRPI0818674B1 (pt) 2023-01-17
AU2008312937A1 (en) 2009-04-23
JP2012143246A (ja) 2012-08-02
IL240122B (en) 2019-02-28
WO2009051108A1 (ja) 2009-04-23
SI2202307T2 (sl) 2021-11-30
CA2701338C (en) 2018-09-18
DK2202307T4 (da) 2021-10-04
US20100291627A1 (en) 2010-11-18
EP2202307B2 (en) 2021-07-14
BRPI0818674A2 (pt) 2014-10-14
CN106244651A (zh) 2016-12-21
ES2499391T5 (es) 2021-12-22
US12145978B2 (en) 2024-11-19
JP2015198663A (ja) 2015-11-12
SI2202307T1 (sl) 2014-11-28
KR20100074184A (ko) 2010-07-01
CN103540632A (zh) 2014-01-29
TW200934867A (en) 2009-08-16
CA2701338A1 (en) 2009-04-23
JP2017079794A (ja) 2017-05-18
PL2202307T5 (pl) 2021-10-04
EP2202307A1 (en) 2010-06-30
US20170275351A1 (en) 2017-09-28
MX2010004007A (es) 2010-06-15
US9683027B2 (en) 2017-06-20
DK2202307T3 (da) 2014-09-15
ES2499391T3 (es) 2014-09-29
CN101802192A (zh) 2010-08-11
US11136375B2 (en) 2021-10-05
US20210300996A1 (en) 2021-09-30
EP2202307B1 (en) 2014-08-20
JP6092304B2 (ja) 2017-03-08
JP6506786B2 (ja) 2019-04-24
JP5788830B2 (ja) 2015-10-07
IL205051A (en) 2015-09-24
JP4976502B2 (ja) 2012-07-18
IL205051A0 (en) 2010-11-30
EP2202307A4 (en) 2012-01-25
TWI463010B (zh) 2014-12-01
AU2008312937B2 (en) 2015-01-22
SG185302A1 (en) 2012-11-29
KR101558009B1 (ko) 2015-10-19

Similar Documents

Publication Publication Date Title
PL2424889T3 (pl) Sposób wytwarzania przeciwciał domenowych
PL1903019T3 (pl) Sposób wytwarzania izoolefin
IL201082A0 (en) Bispecific antibodies and methods for production thereof
EP2157074A4 (en) PROCESS FOR THE PRODUCTION OF ACROLEINE
IL186829A0 (en) Method for production of 1-alkyl- 3 - phenyluracils
IL240122A0 (en) A method for producing an antibody
EP2061812A4 (en) METHOD FOR THE PRODUCTION OF ANTIBODIES
GB0711697D0 (en) Method of manufacture
PL2180052T3 (pl) Sposób wytwarzania L-lizyny
IL197823A0 (en) Methods for improving antibody production
EP2233548A4 (en) PROCESS FOR PRODUCING FERROCOKE
EP2088136A4 (en) PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
EP2221384A4 (en) METHOD FOR MANUFACTURING ANTIBODY
PL2242628T3 (pl) Sposób produkcji rur betonowych
PL2155679T3 (pl) Sposób wytwarzania pochodnych 4-formyloaminopiperydyny
EP2221294A4 (en) PROCESS FOR PREPARING N-CARBAMOYL-TERT.-LEUCIN
PL385356A1 (pl) Sposób wytwarzania tadalafilu
EP2211616A4 (en) PROCESS FOR PREPARING IMIDAZOAZEPINONE COMPOUNDS
EP1997812A4 (en) PROCESS FOR THE PREPARATION OF A CHINAZOLIN-4-ON DERIVATIVE
IL200230A0 (en) Method for the production of ??-ketonitriles
ZA200905055B (en) Method for the production of benzofuran-2-carboxamides
PL382168A1 (pl) Sposób wytwarzania S-(-)- 8-metoksy -2 tetralolu
PL381401A1 (pl) Sposób wytwarzania o-etoksybenzamidu
HK1226780A1 (en) Method for antibody production
GB0619764D0 (en) Method of producing antibodies